Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学HIPEC Peritoneal Mesothelioma, CRS France

Francois Quenet

MD

🏢Institut du Cancer de Montpellier (ICM)🌐France

Professor, Surgical Oncology

37
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Francois Quenet is a French surgical oncologist and senior investigator on the PRODIGE 7 randomized trial, the first phase III study to specifically test the addition of HIPEC to complete cytoreductive surgery for colorectal peritoneal metastases. The trial's finding that HIPEC did not significantly improve overall survival when added to optimal CRS sparked major debate about patient selection and HIPEC technique. He leads research on peritoneal mesothelioma treatment and has refined peritoneal cancer index scoring and completeness of cytoreduction assessment.

Share:

🧪Research Fields 研究领域

PRODIGE 7 trial HIPEC colorectal
peritoneal mesothelioma HIPEC oxaliplatin
French peritoneal oncology group
HIPEC oxaliplatin technique complications
cytoreductive surgery morbidity outcomes

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-04-01 | All information from publicly available academic sources

关注 Francois Quenet 的研究动态

Follow Francois Quenet's research updates

留下邮箱,当我们发布与 Francois Quenet(Institut du Cancer de Montpellier (ICM))相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment